US4349552A
(en)
|
1978-10-30 |
1982-09-14 |
Fujisawa Pharmaceutical Company, Ltd. |
5-Fluorouracil derivatives, and their pharmaceutical compositions
|
PT85662B
(pt)
|
1986-09-10 |
1990-06-29 |
Sandoz Sa |
Processo para a preparacao de derivados de aza-indol e de indolizina e de composicoes farmaceuticas que os contem
|
MX19185A
(es)
|
1989-01-20 |
1993-12-01 |
Pfizer |
Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
DE4304455A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
IL129871A
(en)
*
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
US6075037A
(en)
|
1994-06-09 |
2000-06-13 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
WO2000040554A1
(en)
|
1999-01-07 |
2000-07-13 |
American Home Products Corporation |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
US6313126B1
(en)
|
1999-01-07 |
2001-11-06 |
American Home Products Corp |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
WO2000040581A1
(en)
|
1999-01-07 |
2000-07-13 |
American Home Products Corporation |
3,4-dihydro-2h-benzo[1,4]oxazine derivatives
|
US6265403B1
(en)
|
1999-01-20 |
2001-07-24 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
US20030153560A1
(en)
|
1999-04-23 |
2003-08-14 |
Salituro Francesco G. |
Inhibitors of c-Jun N-terminal kinases (JNK)
|
CA2373883A1
(en)
|
1999-07-02 |
2001-01-11 |
Stuart A. Lipton |
Method of reducing neuronal injury or apoptosis
|
GB9919843D0
(en)
|
1999-08-20 |
1999-10-27 |
Smithkline Beecham Plc |
Novel compounds
|
DE19948417A1
(de)
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
DE60043397D1
(de)
|
1999-12-28 |
2010-01-07 |
Pharmacopeia Inc |
Cytokine, insbesondere tnf-alpha, hemmer
|
AU2001237041B9
(en)
|
2000-02-17 |
2005-07-28 |
Amgen Inc. |
Kinase inhibitors
|
US7041277B2
(en)
|
2000-03-10 |
2006-05-09 |
Cadbury Adams Usa Llc |
Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
EP1309592B9
(en)
|
2000-08-14 |
2007-02-28 |
Ortho-McNeil Pharmaceutical, Inc. |
Substituted pyrazoles
|
WO2002020013A2
(en)
|
2000-09-06 |
2002-03-14 |
Ortho Mcneil Pharmaceutical, Inc. |
A method for treating allergies using substituted pyrazoles
|
EP1315741A2
(en)
|
2000-09-06 |
2003-06-04 |
Ortho-McNeil Pharmaceutical, Inc. |
A method for treating allergies
|
AR031130A1
(es)
|
2000-09-20 |
2003-09-10 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
CA2432654A1
(en)
|
2000-12-22 |
2002-07-04 |
Wyeth |
Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
|
ES2360205T3
(es)
|
2001-03-02 |
2011-06-01 |
Agennix Ag |
Sistema de ensayo de tres híbridos.
|
ES2230484T3
(es)
|
2001-03-14 |
2005-05-01 |
Wyeth |
Derivados antidepresivos azaheterociclimeticos de 2,3-dihidro-1,4-dioxino (2,3-f) quinolina.
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
AU2002258971A1
(en)
|
2001-04-24 |
2002-11-05 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
US6656950B2
(en)
|
2001-04-25 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
|
WO2002088129A1
(en)
|
2001-04-26 |
2002-11-07 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
|
US6573283B2
(en)
|
2001-04-26 |
2003-06-03 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
|
CA2445581A1
(en)
|
2001-04-26 |
2002-11-07 |
Jonathan Laird Gross |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
|
US6593350B2
(en)
|
2001-04-26 |
2003-07-15 |
Wyeth |
Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
|
US6552049B2
(en)
|
2001-04-26 |
2003-04-22 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
|
TR200402753T4
(tr)
|
2001-04-30 |
2004-11-22 |
Wyeth |
7,8-Dihidro-1,6,9-trioksa-3-aza-siklopenta[a]naftalen'in antidepresan azaheterosiklmetil türevleri.
|
US6555560B2
(en)
|
2001-04-30 |
2003-04-29 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
EP1387845A2
(en)
|
2001-05-17 |
2004-02-11 |
Wyeth |
PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE
|
WO2002102800A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
US6903110B2
(en)
|
2001-07-25 |
2005-06-07 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
|
EP1417967A4
(en)
|
2001-08-14 |
2007-03-28 |
Toyama Chemical Co Ltd |
NEW VIRUS PROTECTION INHIBITION, VIRCIDIDIC PROCEDURE AND NEW PYRADIN NUCLEOTIDE / PYRADIN NUCLEOSIDE ANALOGON
|
US20040236110A1
(en)
|
2001-09-26 |
2004-11-25 |
Ladouceur Gaetan H |
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
|
WO2003031439A1
(en)
|
2001-10-05 |
2003-04-17 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
|
US7361671B2
(en)
|
2001-11-15 |
2008-04-22 |
The Institute For Pharmaceutical Discovery, Inc. |
Substituted heteroarylalkanoic acids
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
EP1506189A1
(en)
|
2002-04-26 |
2005-02-16 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
ATE308544T1
(de)
|
2002-04-26 |
2005-11-15 |
Pfizer Prod Inc |
N-substituiete heteroaryloxy-aryl-spiro- pyrimidine-2,4,6-trion metalloproteinase inhibitoren
|
TW200406385A
(en)
|
2002-05-31 |
2004-05-01 |
Eisai Co Ltd |
Pyrazole compound and pharmaceutical composition containing the same
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
EA200500299A1
(ru)
|
2002-08-02 |
2005-08-25 |
Вертекс Фармасьютикалз Инкорпорейтед |
Пиразольные композиции, используемые в качестве ингибиторов gsk-3
|
AU2002368154A1
(en)
|
2002-08-08 |
2004-02-25 |
Ribapharm Inc. |
Improved synthesis for hydroxyalkylated heterocyclic bases
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
EA008778B1
(ru)
|
2003-02-26 |
2007-08-31 |
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг |
Дигидроптеридиноны, способ их получения и их применение в качестве лекарственных средств
|
EP2295433A3
(en)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK inhibitors
|
CA2518318A1
(en)
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
WO2004106298A1
(en)
|
2003-05-30 |
2004-12-09 |
Janssen Pharmaceutica N.V. |
Indole derivatives with an improved antipsychotic activity
|
WO2005000813A1
(en)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
JP2007507529A
(ja)
|
2003-09-30 |
2007-03-29 |
サイオス・インコーポレーテツド |
複素環式アミドおよびスルホンアミド
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
CA2550361C
(en)
|
2003-12-19 |
2014-04-29 |
Prabha Ibrahim |
Compounds and methods for development of ret modulators
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
US7507826B2
(en)
|
2004-03-30 |
2009-03-24 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of JAK and other protein kinases
|
RU2006138621A
(ru)
|
2004-04-02 |
2008-05-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Азаиндолы, полезные в качестве ингибиторов rock и других протеинкиназ
|
ITMI20040874A1
(it)
|
2004-04-30 |
2004-07-30 |
Ist Naz Stud Cura Dei Tumori |
Derivati indolici ed azaindolici con azione antitumorale
|
KR100476851B1
(ko)
|
2004-05-18 |
2005-03-17 |
(주)성신엔지니어링 |
중력식 섬유여과기
|
TW200616632A
(en)
|
2004-06-17 |
2006-06-01 |
Plexxikon Inc |
Compounds modulating c-kit activity and uses therefor
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
US7173031B2
(en)
|
2004-06-28 |
2007-02-06 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
US20060122213A1
(en)
|
2004-06-30 |
2006-06-08 |
Francoise Pierard |
Azaindoles useful as inhibitors of protein kinases
|
NZ553267A
(en)
|
2004-07-27 |
2010-09-30 |
Sgx Pharmaceuticals Inc |
Pyrrolo-pyridine kinase modulators
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
EP1799684B1
(en)
|
2004-10-04 |
2014-12-03 |
Millennium Pharmaceuticals, Inc. |
Lactam compounds useful as protein kinase inhibitors
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
PT1812440E
(pt)
|
2004-11-04 |
2011-01-25 |
Vertex Pharma |
Pirazolo[1,5-a]pirimidinas úteis enquanto inibidores de proteínas cinases
|
RU2394825C2
(ru)
|
2004-11-22 |
2010-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Пирролопиразины, пригодные в качестве ингибиторов киназы аврора а
|
EP1828180A4
(en)
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
EP1831168B1
(en)
|
2004-12-16 |
2014-07-02 |
Vertex Pharmaceuticals Inc. |
Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases.
|
US20060161001A1
(en)
|
2004-12-20 |
2006-07-20 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
RU2434871C2
(ru)
|
2005-02-03 |
2011-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Пирролопиримидины, применимые в качестве ингибиторов протеинкиназы
|
DE602006014540D1
(en)
|
2005-05-16 |
2010-07-08 |
Irm Llc |
Pyrrolopyridinderivate als proteinkinaseinhibitoren
|
KR20080016659A
(ko)
|
2005-05-20 |
2008-02-21 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제의 억제제로서 유용한 피롤로피리딘
|
MY153898A
(en)
*
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
RU2008117151A
(ru)
|
2005-09-30 |
2009-11-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Деазапурины, пригодные в качестве ингибиторов янус-киназ
|
CA2628179A1
(en)
|
2005-11-15 |
2007-05-24 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
US20130096302A1
(en)
|
2005-11-22 |
2013-04-18 |
Hayley Binch |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
EP2559694A3
(en)
|
2006-01-17 |
2013-04-03 |
Vertex Pharmaceuticals, Inc. |
Azaindoles useful as inhibitors of Janus kinases
|
TW200804389A
(en)
|
2006-02-14 |
2008-01-16 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
JP2009528991A
(ja)
|
2006-02-14 |
2009-08-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なピロロ(3,2−c)ピリジン
|
DE102006012617A1
(de)
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
WO2007117494A1
(en)
|
2006-04-05 |
2007-10-18 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of janus kinases
|
MX2008013582A
(es)
|
2006-04-26 |
2009-01-19 |
Hoffmann La Roche |
Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa.
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
JP5642963B2
(ja)
|
2006-06-30 |
2014-12-17 |
スネシス ファーマシューティカルズ,インコーポレイティド |
ピリジノニルpdk1阻害剤
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
KR101435692B1
(ko)
|
2006-08-08 |
2014-09-01 |
추가이 세이야쿠 가부시키가이샤 |
Pi3k 저해제로서의 피리미딘 유도체 및 그의 용도
|
EP2057140B1
(en)
|
2006-08-24 |
2012-08-08 |
AstraZeneca AB |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
US20130310418A1
(en)
|
2006-11-15 |
2013-11-21 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
AU2007334379B2
(en)
|
2006-12-14 |
2013-04-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinase inhibitors
|
EP2815750A1
(en)
|
2006-12-21 |
2014-12-24 |
Vertex Pharmaceuticals Incorporated |
5-cyano-4-(pyrrolo [2,3b] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
|
TW200840581A
(en)
|
2007-02-28 |
2008-10-16 |
Astrazeneca Ab |
Novel pyrimidine derivatives
|
AU2008226461A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines useful as inhibitors of protein kinases
|
CA2679884A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
NZ579485A
(en)
|
2007-03-09 |
2012-02-24 |
Vertex Pharma |
Aminopyrimidines useful as inhibitors of protein kinases
|
PT2139892E
(pt)
|
2007-03-22 |
2011-11-21 |
Takeda Pharmaceutical |
Pirimidodiazepinas substituídas úteis como inibidores da plk1
|
RU2334747C1
(ru)
|
2007-04-05 |
2008-09-27 |
Андрей Александрович Иващенко |
ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
RU2339637C1
(ru)
|
2007-04-05 |
2008-11-27 |
Андрей Александрович Иващенко |
Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
|
EP2176261B1
(en)
|
2007-07-31 |
2012-12-19 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
US8461149B2
(en)
|
2007-08-15 |
2013-06-11 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinase inhibitors
|
ES2585110T3
(es)
|
2007-09-28 |
2016-10-03 |
Cyclacel Limited |
Derivados de pirimidina como inhibidores de proteína cinasa
|
KR101672554B1
(ko)
|
2007-10-09 |
2016-11-03 |
유럽피안 몰레큘러 바이올로지 래보러토리 |
Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편
|
ES2389992T3
(es)
|
2007-11-02 |
2012-11-05 |
Vertex Pharmaceuticals Incorporated |
Derivados de [1H-pirazolo[3,4-b]piridin-4-il]-fenilo o -piridin-2-ilo como proteína cinasa c-theta
|
SI2207775T1
(sl)
|
2007-11-05 |
2012-05-31 |
Novartis Ag |
benzilamino karboksiacil piperidinski derivati kot inhibitorji CETP uporabni za zdravljenje bolezni kot je hiperlipidemija ali arterioskleroza
|
PT2247592E
(pt)
|
2008-02-25 |
2011-11-03 |
Hoffmann La Roche |
Inibidores de pirrolpirazina-cinase
|
EP2262498A2
(en)
|
2008-03-10 |
2010-12-22 |
Vertex Pharmceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
WO2009125395A1
(en)
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
CN102076690A
(zh)
|
2008-06-23 |
2011-05-25 |
维泰克斯制药公司 |
蛋白激酶抑制剂
|
CN102076691A
(zh)
|
2008-06-23 |
2011-05-25 |
维泰克斯制药公司 |
蛋白激酶抑制剂
|
JP2011529066A
(ja)
|
2008-07-23 |
2011-12-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
三環式ピラゾロピリジンキナーゼ阻害剤
|
JP2011529062A
(ja)
|
2008-07-23 |
2011-12-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ピラゾロピリジンキナーゼ阻害剤
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
WO2010011762A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
CN102131809A
(zh)
|
2008-07-23 |
2011-07-20 |
沃泰克斯药物股份有限公司 |
三环吡唑并吡啶激酶抑制剂
|
JP5627675B2
(ja)
|
2009-05-06 |
2014-11-19 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
ピラゾロピリジン
|
CN104922128B
(zh)
|
2009-06-17 |
2019-12-20 |
沃泰克斯药物股份有限公司 |
流感病毒复制抑制剂
|
WO2011000566A2
(en)
|
2009-06-30 |
2011-01-06 |
Savira Pharmaceuticals Gmbh |
Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
|
WO2011008915A1
(en)
|
2009-07-15 |
2011-01-20 |
Abbott Laboratories |
Pyrrolopyridine inhibitors of kinases
|
JP5685895B2
(ja)
*
|
2009-12-11 |
2015-03-18 |
株式会社リコー |
画像処理装置、画像処理方法およびプログラム
|
AR081069A1
(es)
|
2010-04-07 |
2012-06-06 |
Vertex Pharma |
Formas solidas del acido 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoico
|
CN102985424B
(zh)
|
2010-04-14 |
2015-03-11 |
阵列生物制药公司 |
5,7-取代的-咪唑并[1,2-c]嘧啶
|
WO2011137022A1
(en)
|
2010-04-27 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Azaindoles as janus kinase inhibitors
|
RU2013132717A
(ru)
|
2010-12-16 |
2015-01-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы репликации вирусов гриппа
|
CA2822057A1
(en)
|
2010-12-16 |
2012-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
CA2822062A1
(en)
|
2010-12-16 |
2012-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
AU2012279046B2
(en)
|
2011-07-05 |
2017-08-31 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates for producing azaindoles
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
AU2012336019A1
(en)
|
2011-11-07 |
2014-05-29 |
Vertex Pharmaceuticals Incorporated |
Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
|
EP2858984A1
(en)
|
2012-06-08 |
2015-04-15 |
Vertex Pharmaceuticals Inc. |
Inhibitors of influenza viruses replication
|
BR112016005270B1
(pt)
|
2013-09-12 |
2022-11-01 |
Alios Biopharma, Inc |
Compostos de aza-piridona, composições farmacêuticas e seus usos
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
SI3068776T1
(sl)
|
2013-11-13 |
2019-09-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitorji replikacije virusov influence
|
RU2685730C1
(ru)
|
2013-11-13 |
2019-04-23 |
Вертекс Фармасьютикалз Инкорпорейтед |
Составы соединений азаиндола
|
SI3068782T1
(sl)
|
2013-11-13 |
2018-10-30 |
Vertex Pharmaceuticals Incorporated |
Postopki za pripravo inhibitorjev v replikacije virusov gripe
|
US10597390B2
(en)
|
2014-08-08 |
2020-03-24 |
Janssen Sciences Ireland Uc |
Indoles for use in influenza virus infection
|
MX2017002972A
(es)
|
2014-09-08 |
2017-05-30 |
Janssen Sciences Ireland Uc |
Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe.
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
JP6857617B2
(ja)
|
2015-05-13 |
2021-04-14 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤
|
WO2016183116A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
EP3380467B1
(en)
|
2015-11-27 |
2021-07-07 |
Janssen Sciences Ireland Unlimited Company |
Heterocyclic indoles for use in influenza virus infection
|
CA3007758A1
(en)
|
2016-01-07 |
2017-07-13 |
Janssen Sciences Ireland Uc |
Functionalized pentanoic acids for use in influenza viral infections
|
JP6989509B2
(ja)
|
2016-01-20 |
2022-01-05 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
インフルエンザウイルス感染における使用のためのアリール置換ピリミジン
|
WO2017223231A1
(en)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza
|
CA3059362A1
(en)
|
2017-04-12 |
2018-10-18 |
Vertex Pharmaceuticals Incorporated |
Combination therapies for treating influenza virus infection
|